Moreover, other proteins in the pathway, for instance PARP1, have highly specific inhibitors that are currently tested alone or in combination with temozolamide against glioblastoma, both in experimental models and human subjects [84,85,86]. The gene discussed is PARP1; the disease is glioblastoma.